what are the risks of glp-1 for weight loss A major new study found that people taking weight-loss drugs like Ozempic, lower serious obesity-related diseases when they lost significant weight. Patients who reduced their BMI by 15% or Thriving on GLP-1 Medications: How

Fact: Many counterfeit websites use Canadian flags and imagery to look trustworthy while shipping unregulated or contaminated substances from unknown locations

The states with the highest prescribing rates are also among those with greater prevalence of diabetes and obesity, per CDC data, a rough indication that the medicines may be getting to areas where they are in greatest need while shortages, high price tags and insurance restrictions have limited their use

At 56 weeks, the change in body weight was 8% in the liraglutide group and 2.5% in the placebo group, and 63.2% participants in the liraglutide group achieved weight loss of 5% or greater compared with 27.1% of the placebo groups

Patients with a BMI below 27 generally do not meet standard FDA-approved criteria for Semaglutide weight loss treatment